Filing Flows › Progyny (PGNY) › Capital expenditures
Progyny (PGNY) capital expenditures by quarter
Progyny's capital expenditures were $9.4M in Q3 2026 (third quarter 2026), +51% from Q2 2026. Over the last 7 quarters it ranged from $2.8M (Q1 2025) to $9.4M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $9.4M | +51% | +100% |
| Q2 2026 | $6.2M | -2% | +18% |
| Q1 2026 | $6.3M | +13% | +123% |
| Q4 2025 | $5.6M | +20% | — |
| Q3 2025 | $4.7M | -11% | — |
| Q2 2025 | $5.3M | +85% | — |
| Q1 2025 | $2.8M | — | — |
Q3 2026 at a glance
Progyny, Q3 2026: revenue $341M (+9% year over year), operating margin 10.3%, net earnings $26.3M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Progyny's capital expenditures?
Progyny's capital expenditures were $9.4M in Q3 2026 (third quarter 2026), +51% from Q2 2026.
How has Progyny's capital expenditures changed?
Over the last 7 quarters it ranged from $2.8M (Q1 2025) to $9.4M (Q3 2026).